This NDC is on FDA's drug shortage list (posted Jul 14, 2023)

Product Information

LISDEXAMFETAMINE 20 MG TB CHEW is a generic product labeled by Novadoz Pharmaceuticals LLC, priced at $4.3927 per EA under NDC 72205013391. Its NADAC has been published 94 times since Nov 6, 2024.

FDA first approved this application on Feb 2, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LISDEXAMFETAMINE 20 MG TB CHEW

Lisdexamfetamine dimesylate
$4.3927per EA
DEA Schedule CII

Strength

20 mg/1

NDC

72205013391

Classification

Generic

Dosage Form

TABLET, CHEWABLE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

LISDEXAMFETAMINE DIMESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA218306

FDA Approved

2/2/2024

TE Code

AB

On Market Since

2/2/2024

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for LISDEXAMFETAMINE 20 MG TB CHEW has been published 94 times since Nov 6, 2024, and over the history we have for it it has declined 47.1%. The table below summarizes its recorded NADAC range and movement.

Current price$4.3927 per EA
All-time high$8.3615 (May 14, 2025)
All-time low$4.2936 (Jul 22, 2026)
52-week high$7.1531
52-week low$4.2936
Median price$6.6501
Average price$6.4756
Largest weekly change-13.0% (Feb 18, 2026)
Weeks tracked94
Tracking sinceNov 6, 2024

Price History

1W

+2.3%

1M

+2.3%

3M

+1.1%

6M

-10.5%

1Y

-38.6%

3Y

N/A

5Y

N/A

All

-47.1%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LISDEXAMFETAMINE 20 MG TB CHEW?

The current National Average Drug Acquisition Cost (NADAC) for LISDEXAMFETAMINE 20 MG TB CHEW, manufactured by Novadoz Pharmaceuticals LLC, is $4.3927 per EA (NDC 72205013391), effective Aug 19, 2026.

How has the price of LISDEXAMFETAMINE 20 MG TB CHEW changed over time?

Over the history we have for it, the NADAC for LISDEXAMFETAMINE 20 MG TB CHEW has declined 47.1%. It has been tracked across 94 weekly CMS publications since Nov 6, 2024.

What are the highest and lowest recorded NADAC prices for LISDEXAMFETAMINE 20 MG TB CHEW?

Since Nov 6, 2024, the NADAC for LISDEXAMFETAMINE 20 MG TB CHEW has ranged from a low of $4.2936 (Jul 22, 2026) to a high of $8.3615 (May 14, 2025), with a median of $6.6501 per EA.

Are there cheaper alternatives to LISDEXAMFETAMINE 20 MG TB CHEW?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as LISDEXAMFETAMINE 20 MG TB CHEW in a comparable dosage form, but none are currently priced below it.

Who manufactures LISDEXAMFETAMINE 20 MG TB CHEW?

LISDEXAMFETAMINE 20 MG TB CHEW (NDC 72205013391) is labeled by Novadoz Pharmaceuticals LLC, and CMS classifies it as a generic product.

Is LISDEXAMFETAMINE 20 MG TB CHEW in shortage?

Yes — NDC 72205013391 is currently listed in FDA's drug shortage database (posted Jul 14, 2023).